Migden M, Schmults C, Khushalani N, Guminski A, Chang AL, Lewis K, Ansstas G, Bowyer S, Hughes B, Schadendorf D, Modi B, Dunn L, Flatz L, Hauschild A, Yoo S-Y, Booth J, Seebach F, Lowy I, Fury M, Rischin D. Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s176. Available from: https://jofskin.org/33014/index.php/skin/article/view/2001